Global Passive Transdermal Drug Delivery Device Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Passive Transdermal Drug Delivery Device market size was valued at US$ 5145 million in 2025 and is forecast to a readjusted size of US$ 7287 million by 2032 with a CAGR of 4.8% during review period.
A passive transdermal drug delivery device refers to a category of drug delivery instruments that rely solely on the drug's own diffusion characteristics to penetrate the skin barrier and enter the body to exert therapeutic effects. Its technical essence lies in utilizing the concentration gradient as the driving force, allowing drug molecules to naturally diffuse from high-concentration areas to low-concentration areas without the need for any external energy. From a product morphology perspective, the transdermal patch is the most typical representative of passive transdermal drug delivery devices, typically consisting of a backing layer, drug reservoir, adhesive layer, rate-controlling membrane, and release liner, achieving controlled drug dosage by adjusting the application duration. According to a 2011 technical article in Electronic Technology Application, external patches are the most commonly used passive drug delivery method, safely and comfortably delivering a certain dose of medication to patients over a defined period, with the drug entering the bloodstream through skin absorption. Nicotine patches are the classic example of such devices, with other common applications including motion sickness treatment, hormone replacement therapy, and contraception. Additionally, gels, plasters, microemulsions, and flexible liposomes (such as transfersomes) also fall within the category of passive transdermal drug delivery. A 2024 review in Molecular Pharmaceutics noted that transdermal drug delivery systems (TDDS) have become an important technology platform in the field of drug delivery due to their non-invasive nature, patient convenience, and ability to bypass first-pass metabolism associated with oral administration. Currently, passive transdermal drug delivery devices are expanding from traditional small-molecule drug delivery toward the delivery of biologics such as peptides and proteins, with their industrial value continuing to grow alongside the increasing demand for chronic disease management.
Market Development Opportunities and Key Drivers
A 2025 study published in the Journal of Nanobiotechnology proposed a two-stage transdermal drug delivery system based on sonophase-change transfersomes (SPCTs), combining passive penetration with ultrasound-triggered active permeation. Kindeva noted in January 2026 that skin delivery is gaining increasing attention, with patients and healthcare systems seeking needle-free, home-based drug delivery options. A 2024 review in Molecular Pharmaceutics systematically analyzed the development and failure modes of transdermal drug delivery systems, providing the industry with strategies for risk mitigation. The long-term treatment needs of chronic disease management are driving expanded insurance coverage for transdermal drug delivery devices.
Market Challenges and Risks
Skin impedance is complex and variable, influenced by factors such as age, ethnicity, and body weight, making precise control of drug absorption rates difficult. Currently, only small-molecule lipophilic drugs with molecular weights below 500 Da can penetrate the skin barrier at acceptable rates. While novel carriers such as transfersomes and microemulsions can enhance the transdermal penetration of macromolecular drugs, their industrial-scale manufacturing processes, batch consistency, and long-term stability still require validation. The adhesive system itself can also be a source of failure, as certain adhesives may not be suitable for all skin types and their properties can be affected by sweating, bathing, or swimming.
Downstream Demand Trends
Transdermal patches for drugs such as fentanyl and buprenorphine have become a long-term treatment option for moderate to severe pain. Transdermal drug delivery systems have been applied to a range of drugs including nicotine, fentanyl, nitroglycerin, and clonidine, with ongoing exploration of their potential for biologic delivery. Nitroglycerin patches are used for angina prophylaxis, clonidine patches for hypertension treatment, and rivastigmine patches for Alzheimer's disease, offering an alternative route for patients with dysphagia. Contraceptive patches and hormone replacement patches are well-established products, while transdermal patches containing active ingredients such as caffeine and vitamins are entering the market as functional consumer goods.
Regional Trends
North America, leveraging its mature innovation ecosystem and rapid regulatory pathways, continues to lead source innovation in transdermal drug delivery technology, with CDMOs such as Kindeva providing end-to-end services from formulation development to large-scale manufacturing. Europe maintains its advantage in basic research and clinical evidence accumulation, with Germany's LTS Lohmann Therapie-Systeme AG holding over 20 marketed products and more than 50 projects in development. In the Asia-Pacific region, China is emerging as the most dynamic growth market. Domestic companies such as MicroCore have achieved mass production of microneedle patches, with an annual capacity in the tens of millions of units; Jiangsu Kangbeide Pharmaceutical possesses three platform technologies for transdermal formulations and has passed GMP inspections. Universities such as East China University of Science and Technology continue to generate innovations in novel carriers such as transfersomes and flexible liposomes.
This report is a detailed and comprehensive analysis for global Passive Transdermal Drug Delivery Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Passive Transdermal Drug Delivery Device market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2021-2032
Global Passive Transdermal Drug Delivery Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2021-2032
Global Passive Transdermal Drug Delivery Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2021-2032
Global Passive Transdermal Drug Delivery Device market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (USD/Unit), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Passive Transdermal Drug Delivery Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Passive Transdermal Drug Delivery Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Passive Transdermal Drug Delivery Device, with price, sales quantity, revenue, and global market share of Passive Transdermal Drug Delivery Device from 2021 to 2026.
Chapter 3, the Passive Transdermal Drug Delivery Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Passive Transdermal Drug Delivery Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Passive Transdermal Drug Delivery Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Passive Transdermal Drug Delivery Device.
Chapter 14 and 15, to describe Passive Transdermal Drug Delivery Device sales channel, distributors, customers, research findings and conclusion.
A passive transdermal drug delivery device refers to a category of drug delivery instruments that rely solely on the drug's own diffusion characteristics to penetrate the skin barrier and enter the body to exert therapeutic effects. Its technical essence lies in utilizing the concentration gradient as the driving force, allowing drug molecules to naturally diffuse from high-concentration areas to low-concentration areas without the need for any external energy. From a product morphology perspective, the transdermal patch is the most typical representative of passive transdermal drug delivery devices, typically consisting of a backing layer, drug reservoir, adhesive layer, rate-controlling membrane, and release liner, achieving controlled drug dosage by adjusting the application duration. According to a 2011 technical article in Electronic Technology Application, external patches are the most commonly used passive drug delivery method, safely and comfortably delivering a certain dose of medication to patients over a defined period, with the drug entering the bloodstream through skin absorption. Nicotine patches are the classic example of such devices, with other common applications including motion sickness treatment, hormone replacement therapy, and contraception. Additionally, gels, plasters, microemulsions, and flexible liposomes (such as transfersomes) also fall within the category of passive transdermal drug delivery. A 2024 review in Molecular Pharmaceutics noted that transdermal drug delivery systems (TDDS) have become an important technology platform in the field of drug delivery due to their non-invasive nature, patient convenience, and ability to bypass first-pass metabolism associated with oral administration. Currently, passive transdermal drug delivery devices are expanding from traditional small-molecule drug delivery toward the delivery of biologics such as peptides and proteins, with their industrial value continuing to grow alongside the increasing demand for chronic disease management.
Market Development Opportunities and Key Drivers
A 2025 study published in the Journal of Nanobiotechnology proposed a two-stage transdermal drug delivery system based on sonophase-change transfersomes (SPCTs), combining passive penetration with ultrasound-triggered active permeation. Kindeva noted in January 2026 that skin delivery is gaining increasing attention, with patients and healthcare systems seeking needle-free, home-based drug delivery options. A 2024 review in Molecular Pharmaceutics systematically analyzed the development and failure modes of transdermal drug delivery systems, providing the industry with strategies for risk mitigation. The long-term treatment needs of chronic disease management are driving expanded insurance coverage for transdermal drug delivery devices.
Market Challenges and Risks
Skin impedance is complex and variable, influenced by factors such as age, ethnicity, and body weight, making precise control of drug absorption rates difficult. Currently, only small-molecule lipophilic drugs with molecular weights below 500 Da can penetrate the skin barrier at acceptable rates. While novel carriers such as transfersomes and microemulsions can enhance the transdermal penetration of macromolecular drugs, their industrial-scale manufacturing processes, batch consistency, and long-term stability still require validation. The adhesive system itself can also be a source of failure, as certain adhesives may not be suitable for all skin types and their properties can be affected by sweating, bathing, or swimming.
Downstream Demand Trends
Transdermal patches for drugs such as fentanyl and buprenorphine have become a long-term treatment option for moderate to severe pain. Transdermal drug delivery systems have been applied to a range of drugs including nicotine, fentanyl, nitroglycerin, and clonidine, with ongoing exploration of their potential for biologic delivery. Nitroglycerin patches are used for angina prophylaxis, clonidine patches for hypertension treatment, and rivastigmine patches for Alzheimer's disease, offering an alternative route for patients with dysphagia. Contraceptive patches and hormone replacement patches are well-established products, while transdermal patches containing active ingredients such as caffeine and vitamins are entering the market as functional consumer goods.
Regional Trends
North America, leveraging its mature innovation ecosystem and rapid regulatory pathways, continues to lead source innovation in transdermal drug delivery technology, with CDMOs such as Kindeva providing end-to-end services from formulation development to large-scale manufacturing. Europe maintains its advantage in basic research and clinical evidence accumulation, with Germany's LTS Lohmann Therapie-Systeme AG holding over 20 marketed products and more than 50 projects in development. In the Asia-Pacific region, China is emerging as the most dynamic growth market. Domestic companies such as MicroCore have achieved mass production of microneedle patches, with an annual capacity in the tens of millions of units; Jiangsu Kangbeide Pharmaceutical possesses three platform technologies for transdermal formulations and has passed GMP inspections. Universities such as East China University of Science and Technology continue to generate innovations in novel carriers such as transfersomes and flexible liposomes.
This report is a detailed and comprehensive analysis for global Passive Transdermal Drug Delivery Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Passive Transdermal Drug Delivery Device market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2021-2032
Global Passive Transdermal Drug Delivery Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2021-2032
Global Passive Transdermal Drug Delivery Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2021-2032
Global Passive Transdermal Drug Delivery Device market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (USD/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Passive Transdermal Drug Delivery Device
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Passive Transdermal Drug Delivery Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Patch Drug Delivery
- Cream Drug Delivery
- Plaster Drug Delivery
- Microneedle Drug Delivery
- Liposome Drug Delivery
- Small Molecule Drugs
- Protein Drugs
- Nucleic Acid Drugs
- Diffusion Only Drug Delivery
- Penetration Enhancer Assisted Drug Delivery
- Carrier Mediated Drug Delivery
- Immediate Release Drug Delivery
- Sustained Release Drug Delivery
- Controlled Release Drug Delivery
- Neurological Disorders Treatment
- Cardiovascular Diseases Treatment
- Hormone Replacement Therapy
- Hisamitsu
- LTS Lohmann Therapie-Systeme
- Teikoku
- Nitto Denko
- MedPharm
- NexGel
- Kindeva Drug Delivery
- Noven
- Teikoku Seiyaku
- Ildong Pharmaceutical
- PassPort Technologies
- Hayao Group
- Lingrui Pharmaceutical
- CAS Microneedle
- Luye
- Tide Pharmaceutical
- Jiudian Pharmaceutical
- LianSN Pharm
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Passive Transdermal Drug Delivery Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Passive Transdermal Drug Delivery Device, with price, sales quantity, revenue, and global market share of Passive Transdermal Drug Delivery Device from 2021 to 2026.
Chapter 3, the Passive Transdermal Drug Delivery Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Passive Transdermal Drug Delivery Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Passive Transdermal Drug Delivery Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Passive Transdermal Drug Delivery Device.
Chapter 14 and 15, to describe Passive Transdermal Drug Delivery Device sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Passive Transdermal Drug Delivery Device Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Patch Drug Delivery
1.3.3 Cream Drug Delivery
1.3.4 Plaster Drug Delivery
1.3.5 Microneedle Drug Delivery
1.3.6 Liposome Drug Delivery
1.4 Market Analysis by Drug Type
1.4.1 Overview: Global Passive Transdermal Drug Delivery Device Consumption Value by Drug Type: 2021 Versus 2025 Versus 2032
1.4.2 Small Molecule Drugs
1.4.3 Protein Drugs
1.4.4 Nucleic Acid Drugs
1.5 Market Analysis by Interaction Mechanism
1.5.1 Overview: Global Passive Transdermal Drug Delivery Device Consumption Value by Interaction Mechanism: 2021 Versus 2025 Versus 2032
1.5.2 Diffusion Only Drug Delivery
1.5.3 Penetration Enhancer Assisted Drug Delivery
1.5.4 Carrier Mediated Drug Delivery
1.6 Market Analysis by Drug Release Rate
1.6.1 Overview: Global Passive Transdermal Drug Delivery Device Consumption Value by Drug Release Rate: 2021 Versus 2025 Versus 2032
1.6.2 Immediate Release Drug Delivery
1.6.3 Sustained Release Drug Delivery
1.6.4 Controlled Release Drug Delivery
1.7 Market Analysis by Application
1.7.1 Overview: Global Passive Transdermal Drug Delivery Device Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.7.2 Neurological Disorders Treatment
1.7.3 Cardiovascular Diseases Treatment
1.7.4 Hormone Replacement Therapy
1.8 Global Passive Transdermal Drug Delivery Device Market Size & Forecast
1.8.1 Global Passive Transdermal Drug Delivery Device Consumption Value (2021 & 2025 & 2032)
1.8.2 Global Passive Transdermal Drug Delivery Device Sales Quantity (2021-2032)
1.8.3 Global Passive Transdermal Drug Delivery Device Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Hisamitsu
2.1.1 Hisamitsu Details
2.1.2 Hisamitsu Major Business
2.1.3 Hisamitsu Passive Transdermal Drug Delivery Device Product and Services
2.1.4 Hisamitsu Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Hisamitsu Recent Developments/Updates
2.2 LTS Lohmann Therapie-Systeme
2.2.1 LTS Lohmann Therapie-Systeme Details
2.2.2 LTS Lohmann Therapie-Systeme Major Business
2.2.3 LTS Lohmann Therapie-Systeme Passive Transdermal Drug Delivery Device Product and Services
2.2.4 LTS Lohmann Therapie-Systeme Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 LTS Lohmann Therapie-Systeme Recent Developments/Updates
2.3 Teikoku
2.3.1 Teikoku Details
2.3.2 Teikoku Major Business
2.3.3 Teikoku Passive Transdermal Drug Delivery Device Product and Services
2.3.4 Teikoku Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Teikoku Recent Developments/Updates
2.4 Nitto Denko
2.4.1 Nitto Denko Details
2.4.2 Nitto Denko Major Business
2.4.3 Nitto Denko Passive Transdermal Drug Delivery Device Product and Services
2.4.4 Nitto Denko Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Nitto Denko Recent Developments/Updates
2.5 MedPharm
2.5.1 MedPharm Details
2.5.2 MedPharm Major Business
2.5.3 MedPharm Passive Transdermal Drug Delivery Device Product and Services
2.5.4 MedPharm Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 MedPharm Recent Developments/Updates
2.6 NexGel
2.6.1 NexGel Details
2.6.2 NexGel Major Business
2.6.3 NexGel Passive Transdermal Drug Delivery Device Product and Services
2.6.4 NexGel Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 NexGel Recent Developments/Updates
2.7 Kindeva Drug Delivery
2.7.1 Kindeva Drug Delivery Details
2.7.2 Kindeva Drug Delivery Major Business
2.7.3 Kindeva Drug Delivery Passive Transdermal Drug Delivery Device Product and Services
2.7.4 Kindeva Drug Delivery Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Kindeva Drug Delivery Recent Developments/Updates
2.8 Noven
2.8.1 Noven Details
2.8.2 Noven Major Business
2.8.3 Noven Passive Transdermal Drug Delivery Device Product and Services
2.8.4 Noven Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Noven Recent Developments/Updates
2.9 Teikoku Seiyaku
2.9.1 Teikoku Seiyaku Details
2.9.2 Teikoku Seiyaku Major Business
2.9.3 Teikoku Seiyaku Passive Transdermal Drug Delivery Device Product and Services
2.9.4 Teikoku Seiyaku Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Teikoku Seiyaku Recent Developments/Updates
2.10 Ildong Pharmaceutical
2.10.1 Ildong Pharmaceutical Details
2.10.2 Ildong Pharmaceutical Major Business
2.10.3 Ildong Pharmaceutical Passive Transdermal Drug Delivery Device Product and Services
2.10.4 Ildong Pharmaceutical Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Ildong Pharmaceutical Recent Developments/Updates
2.11 PassPort Technologies
2.11.1 PassPort Technologies Details
2.11.2 PassPort Technologies Major Business
2.11.3 PassPort Technologies Passive Transdermal Drug Delivery Device Product and Services
2.11.4 PassPort Technologies Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 PassPort Technologies Recent Developments/Updates
2.12 Hayao Group
2.12.1 Hayao Group Details
2.12.2 Hayao Group Major Business
2.12.3 Hayao Group Passive Transdermal Drug Delivery Device Product and Services
2.12.4 Hayao Group Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Hayao Group Recent Developments/Updates
2.13 Lingrui Pharmaceutical
2.13.1 Lingrui Pharmaceutical Details
2.13.2 Lingrui Pharmaceutical Major Business
2.13.3 Lingrui Pharmaceutical Passive Transdermal Drug Delivery Device Product and Services
2.13.4 Lingrui Pharmaceutical Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Lingrui Pharmaceutical Recent Developments/Updates
2.14 CAS Microneedle
2.14.1 CAS Microneedle Details
2.14.2 CAS Microneedle Major Business
2.14.3 CAS Microneedle Passive Transdermal Drug Delivery Device Product and Services
2.14.4 CAS Microneedle Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 CAS Microneedle Recent Developments/Updates
2.15 Luye
2.15.1 Luye Details
2.15.2 Luye Major Business
2.15.3 Luye Passive Transdermal Drug Delivery Device Product and Services
2.15.4 Luye Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Luye Recent Developments/Updates
2.16 Tide Pharmaceutical
2.16.1 Tide Pharmaceutical Details
2.16.2 Tide Pharmaceutical Major Business
2.16.3 Tide Pharmaceutical Passive Transdermal Drug Delivery Device Product and Services
2.16.4 Tide Pharmaceutical Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Tide Pharmaceutical Recent Developments/Updates
2.17 Jiudian Pharmaceutical
2.17.1 Jiudian Pharmaceutical Details
2.17.2 Jiudian Pharmaceutical Major Business
2.17.3 Jiudian Pharmaceutical Passive Transdermal Drug Delivery Device Product and Services
2.17.4 Jiudian Pharmaceutical Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Jiudian Pharmaceutical Recent Developments/Updates
2.18 LianSN Pharm
2.18.1 LianSN Pharm Details
2.18.2 LianSN Pharm Major Business
2.18.3 LianSN Pharm Passive Transdermal Drug Delivery Device Product and Services
2.18.4 LianSN Pharm Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 LianSN Pharm Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PASSIVE TRANSDERMAL DRUG DELIVERY DEVICE BY MANUFACTURER
3.1 Global Passive Transdermal Drug Delivery Device Sales Quantity by Manufacturer (2021-2026)
3.2 Global Passive Transdermal Drug Delivery Device Revenue by Manufacturer (2021-2026)
3.3 Global Passive Transdermal Drug Delivery Device Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Passive Transdermal Drug Delivery Device by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Passive Transdermal Drug Delivery Device Manufacturer Market Share in 2025
3.4.3 Top 6 Passive Transdermal Drug Delivery Device Manufacturer Market Share in 2025
3.5 Passive Transdermal Drug Delivery Device Market: Overall Company Footprint Analysis
3.5.1 Passive Transdermal Drug Delivery Device Market: Region Footprint
3.5.2 Passive Transdermal Drug Delivery Device Market: Company Product Type Footprint
3.5.3 Passive Transdermal Drug Delivery Device Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Passive Transdermal Drug Delivery Device Market Size by Region
4.1.1 Global Passive Transdermal Drug Delivery Device Sales Quantity by Region (2021-2032)
4.1.2 Global Passive Transdermal Drug Delivery Device Consumption Value by Region (2021-2032)
4.1.3 Global Passive Transdermal Drug Delivery Device Average Price by Region (2021-2032)
4.2 North America Passive Transdermal Drug Delivery Device Consumption Value (2021-2032)
4.3 Europe Passive Transdermal Drug Delivery Device Consumption Value (2021-2032)
4.4 Asia-Pacific Passive Transdermal Drug Delivery Device Consumption Value (2021-2032)
4.5 South America Passive Transdermal Drug Delivery Device Consumption Value (2021-2032)
4.6 Middle East & Africa Passive Transdermal Drug Delivery Device Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2032)
5.2 Global Passive Transdermal Drug Delivery Device Consumption Value by Type (2021-2032)
5.3 Global Passive Transdermal Drug Delivery Device Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2032)
6.2 Global Passive Transdermal Drug Delivery Device Consumption Value by Application (2021-2032)
6.3 Global Passive Transdermal Drug Delivery Device Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2032)
7.2 North America Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2032)
7.3 North America Passive Transdermal Drug Delivery Device Market Size by Country
7.3.1 North America Passive Transdermal Drug Delivery Device Sales Quantity by Country (2021-2032)
7.3.2 North America Passive Transdermal Drug Delivery Device Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2032)
8.2 Europe Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2032)
8.3 Europe Passive Transdermal Drug Delivery Device Market Size by Country
8.3.1 Europe Passive Transdermal Drug Delivery Device Sales Quantity by Country (2021-2032)
8.3.2 Europe Passive Transdermal Drug Delivery Device Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Passive Transdermal Drug Delivery Device Market Size by Region
9.3.1 Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Passive Transdermal Drug Delivery Device Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2032)
10.2 South America Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2032)
10.3 South America Passive Transdermal Drug Delivery Device Market Size by Country
10.3.1 South America Passive Transdermal Drug Delivery Device Sales Quantity by Country (2021-2032)
10.3.2 South America Passive Transdermal Drug Delivery Device Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Passive Transdermal Drug Delivery Device Market Size by Country
11.3.1 Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Passive Transdermal Drug Delivery Device Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Passive Transdermal Drug Delivery Device Market Drivers
12.2 Passive Transdermal Drug Delivery Device Market Restraints
12.3 Passive Transdermal Drug Delivery Device Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Passive Transdermal Drug Delivery Device and Key Manufacturers
13.2 Manufacturing Costs Percentage of Passive Transdermal Drug Delivery Device
13.3 Passive Transdermal Drug Delivery Device Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Passive Transdermal Drug Delivery Device Typical Distributors
14.3 Passive Transdermal Drug Delivery Device Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Passive Transdermal Drug Delivery Device Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Patch Drug Delivery
1.3.3 Cream Drug Delivery
1.3.4 Plaster Drug Delivery
1.3.5 Microneedle Drug Delivery
1.3.6 Liposome Drug Delivery
1.4 Market Analysis by Drug Type
1.4.1 Overview: Global Passive Transdermal Drug Delivery Device Consumption Value by Drug Type: 2021 Versus 2025 Versus 2032
1.4.2 Small Molecule Drugs
1.4.3 Protein Drugs
1.4.4 Nucleic Acid Drugs
1.5 Market Analysis by Interaction Mechanism
1.5.1 Overview: Global Passive Transdermal Drug Delivery Device Consumption Value by Interaction Mechanism: 2021 Versus 2025 Versus 2032
1.5.2 Diffusion Only Drug Delivery
1.5.3 Penetration Enhancer Assisted Drug Delivery
1.5.4 Carrier Mediated Drug Delivery
1.6 Market Analysis by Drug Release Rate
1.6.1 Overview: Global Passive Transdermal Drug Delivery Device Consumption Value by Drug Release Rate: 2021 Versus 2025 Versus 2032
1.6.2 Immediate Release Drug Delivery
1.6.3 Sustained Release Drug Delivery
1.6.4 Controlled Release Drug Delivery
1.7 Market Analysis by Application
1.7.1 Overview: Global Passive Transdermal Drug Delivery Device Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.7.2 Neurological Disorders Treatment
1.7.3 Cardiovascular Diseases Treatment
1.7.4 Hormone Replacement Therapy
1.8 Global Passive Transdermal Drug Delivery Device Market Size & Forecast
1.8.1 Global Passive Transdermal Drug Delivery Device Consumption Value (2021 & 2025 & 2032)
1.8.2 Global Passive Transdermal Drug Delivery Device Sales Quantity (2021-2032)
1.8.3 Global Passive Transdermal Drug Delivery Device Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Hisamitsu
2.1.1 Hisamitsu Details
2.1.2 Hisamitsu Major Business
2.1.3 Hisamitsu Passive Transdermal Drug Delivery Device Product and Services
2.1.4 Hisamitsu Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Hisamitsu Recent Developments/Updates
2.2 LTS Lohmann Therapie-Systeme
2.2.1 LTS Lohmann Therapie-Systeme Details
2.2.2 LTS Lohmann Therapie-Systeme Major Business
2.2.3 LTS Lohmann Therapie-Systeme Passive Transdermal Drug Delivery Device Product and Services
2.2.4 LTS Lohmann Therapie-Systeme Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 LTS Lohmann Therapie-Systeme Recent Developments/Updates
2.3 Teikoku
2.3.1 Teikoku Details
2.3.2 Teikoku Major Business
2.3.3 Teikoku Passive Transdermal Drug Delivery Device Product and Services
2.3.4 Teikoku Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Teikoku Recent Developments/Updates
2.4 Nitto Denko
2.4.1 Nitto Denko Details
2.4.2 Nitto Denko Major Business
2.4.3 Nitto Denko Passive Transdermal Drug Delivery Device Product and Services
2.4.4 Nitto Denko Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Nitto Denko Recent Developments/Updates
2.5 MedPharm
2.5.1 MedPharm Details
2.5.2 MedPharm Major Business
2.5.3 MedPharm Passive Transdermal Drug Delivery Device Product and Services
2.5.4 MedPharm Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 MedPharm Recent Developments/Updates
2.6 NexGel
2.6.1 NexGel Details
2.6.2 NexGel Major Business
2.6.3 NexGel Passive Transdermal Drug Delivery Device Product and Services
2.6.4 NexGel Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 NexGel Recent Developments/Updates
2.7 Kindeva Drug Delivery
2.7.1 Kindeva Drug Delivery Details
2.7.2 Kindeva Drug Delivery Major Business
2.7.3 Kindeva Drug Delivery Passive Transdermal Drug Delivery Device Product and Services
2.7.4 Kindeva Drug Delivery Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Kindeva Drug Delivery Recent Developments/Updates
2.8 Noven
2.8.1 Noven Details
2.8.2 Noven Major Business
2.8.3 Noven Passive Transdermal Drug Delivery Device Product and Services
2.8.4 Noven Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Noven Recent Developments/Updates
2.9 Teikoku Seiyaku
2.9.1 Teikoku Seiyaku Details
2.9.2 Teikoku Seiyaku Major Business
2.9.3 Teikoku Seiyaku Passive Transdermal Drug Delivery Device Product and Services
2.9.4 Teikoku Seiyaku Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Teikoku Seiyaku Recent Developments/Updates
2.10 Ildong Pharmaceutical
2.10.1 Ildong Pharmaceutical Details
2.10.2 Ildong Pharmaceutical Major Business
2.10.3 Ildong Pharmaceutical Passive Transdermal Drug Delivery Device Product and Services
2.10.4 Ildong Pharmaceutical Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Ildong Pharmaceutical Recent Developments/Updates
2.11 PassPort Technologies
2.11.1 PassPort Technologies Details
2.11.2 PassPort Technologies Major Business
2.11.3 PassPort Technologies Passive Transdermal Drug Delivery Device Product and Services
2.11.4 PassPort Technologies Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 PassPort Technologies Recent Developments/Updates
2.12 Hayao Group
2.12.1 Hayao Group Details
2.12.2 Hayao Group Major Business
2.12.3 Hayao Group Passive Transdermal Drug Delivery Device Product and Services
2.12.4 Hayao Group Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Hayao Group Recent Developments/Updates
2.13 Lingrui Pharmaceutical
2.13.1 Lingrui Pharmaceutical Details
2.13.2 Lingrui Pharmaceutical Major Business
2.13.3 Lingrui Pharmaceutical Passive Transdermal Drug Delivery Device Product and Services
2.13.4 Lingrui Pharmaceutical Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Lingrui Pharmaceutical Recent Developments/Updates
2.14 CAS Microneedle
2.14.1 CAS Microneedle Details
2.14.2 CAS Microneedle Major Business
2.14.3 CAS Microneedle Passive Transdermal Drug Delivery Device Product and Services
2.14.4 CAS Microneedle Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 CAS Microneedle Recent Developments/Updates
2.15 Luye
2.15.1 Luye Details
2.15.2 Luye Major Business
2.15.3 Luye Passive Transdermal Drug Delivery Device Product and Services
2.15.4 Luye Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Luye Recent Developments/Updates
2.16 Tide Pharmaceutical
2.16.1 Tide Pharmaceutical Details
2.16.2 Tide Pharmaceutical Major Business
2.16.3 Tide Pharmaceutical Passive Transdermal Drug Delivery Device Product and Services
2.16.4 Tide Pharmaceutical Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Tide Pharmaceutical Recent Developments/Updates
2.17 Jiudian Pharmaceutical
2.17.1 Jiudian Pharmaceutical Details
2.17.2 Jiudian Pharmaceutical Major Business
2.17.3 Jiudian Pharmaceutical Passive Transdermal Drug Delivery Device Product and Services
2.17.4 Jiudian Pharmaceutical Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Jiudian Pharmaceutical Recent Developments/Updates
2.18 LianSN Pharm
2.18.1 LianSN Pharm Details
2.18.2 LianSN Pharm Major Business
2.18.3 LianSN Pharm Passive Transdermal Drug Delivery Device Product and Services
2.18.4 LianSN Pharm Passive Transdermal Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 LianSN Pharm Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PASSIVE TRANSDERMAL DRUG DELIVERY DEVICE BY MANUFACTURER
3.1 Global Passive Transdermal Drug Delivery Device Sales Quantity by Manufacturer (2021-2026)
3.2 Global Passive Transdermal Drug Delivery Device Revenue by Manufacturer (2021-2026)
3.3 Global Passive Transdermal Drug Delivery Device Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Passive Transdermal Drug Delivery Device by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Passive Transdermal Drug Delivery Device Manufacturer Market Share in 2025
3.4.3 Top 6 Passive Transdermal Drug Delivery Device Manufacturer Market Share in 2025
3.5 Passive Transdermal Drug Delivery Device Market: Overall Company Footprint Analysis
3.5.1 Passive Transdermal Drug Delivery Device Market: Region Footprint
3.5.2 Passive Transdermal Drug Delivery Device Market: Company Product Type Footprint
3.5.3 Passive Transdermal Drug Delivery Device Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Passive Transdermal Drug Delivery Device Market Size by Region
4.1.1 Global Passive Transdermal Drug Delivery Device Sales Quantity by Region (2021-2032)
4.1.2 Global Passive Transdermal Drug Delivery Device Consumption Value by Region (2021-2032)
4.1.3 Global Passive Transdermal Drug Delivery Device Average Price by Region (2021-2032)
4.2 North America Passive Transdermal Drug Delivery Device Consumption Value (2021-2032)
4.3 Europe Passive Transdermal Drug Delivery Device Consumption Value (2021-2032)
4.4 Asia-Pacific Passive Transdermal Drug Delivery Device Consumption Value (2021-2032)
4.5 South America Passive Transdermal Drug Delivery Device Consumption Value (2021-2032)
4.6 Middle East & Africa Passive Transdermal Drug Delivery Device Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2032)
5.2 Global Passive Transdermal Drug Delivery Device Consumption Value by Type (2021-2032)
5.3 Global Passive Transdermal Drug Delivery Device Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2032)
6.2 Global Passive Transdermal Drug Delivery Device Consumption Value by Application (2021-2032)
6.3 Global Passive Transdermal Drug Delivery Device Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2032)
7.2 North America Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2032)
7.3 North America Passive Transdermal Drug Delivery Device Market Size by Country
7.3.1 North America Passive Transdermal Drug Delivery Device Sales Quantity by Country (2021-2032)
7.3.2 North America Passive Transdermal Drug Delivery Device Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2032)
8.2 Europe Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2032)
8.3 Europe Passive Transdermal Drug Delivery Device Market Size by Country
8.3.1 Europe Passive Transdermal Drug Delivery Device Sales Quantity by Country (2021-2032)
8.3.2 Europe Passive Transdermal Drug Delivery Device Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Passive Transdermal Drug Delivery Device Market Size by Region
9.3.1 Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Passive Transdermal Drug Delivery Device Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2032)
10.2 South America Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2032)
10.3 South America Passive Transdermal Drug Delivery Device Market Size by Country
10.3.1 South America Passive Transdermal Drug Delivery Device Sales Quantity by Country (2021-2032)
10.3.2 South America Passive Transdermal Drug Delivery Device Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Passive Transdermal Drug Delivery Device Market Size by Country
11.3.1 Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Passive Transdermal Drug Delivery Device Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Passive Transdermal Drug Delivery Device Market Drivers
12.2 Passive Transdermal Drug Delivery Device Market Restraints
12.3 Passive Transdermal Drug Delivery Device Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Passive Transdermal Drug Delivery Device and Key Manufacturers
13.2 Manufacturing Costs Percentage of Passive Transdermal Drug Delivery Device
13.3 Passive Transdermal Drug Delivery Device Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Passive Transdermal Drug Delivery Device Typical Distributors
14.3 Passive Transdermal Drug Delivery Device Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Passive Transdermal Drug Delivery Device Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Passive Transdermal Drug Delivery Device Consumption Value by Drug Type, (USD Million), 2021 & 2025 & 2032
Table 3. Global Passive Transdermal Drug Delivery Device Consumption Value by Interaction Mechanism, (USD Million), 2021 & 2025 & 2032
Table 4. Global Passive Transdermal Drug Delivery Device Consumption Value by Drug Release Rate, (USD Million), 2021 & 2025 & 2032
Table 5. Global Passive Transdermal Drug Delivery Device Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Hisamitsu Basic Information, Manufacturing Base and Competitors
Table 7. Hisamitsu Major Business
Table 8. Hisamitsu Passive Transdermal Drug Delivery Device Product and Services
Table 9. Hisamitsu Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Hisamitsu Recent Developments/Updates
Table 11. LTS Lohmann Therapie-Systeme Basic Information, Manufacturing Base and Competitors
Table 12. LTS Lohmann Therapie-Systeme Major Business
Table 13. LTS Lohmann Therapie-Systeme Passive Transdermal Drug Delivery Device Product and Services
Table 14. LTS Lohmann Therapie-Systeme Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. LTS Lohmann Therapie-Systeme Recent Developments/Updates
Table 16. Teikoku Basic Information, Manufacturing Base and Competitors
Table 17. Teikoku Major Business
Table 18. Teikoku Passive Transdermal Drug Delivery Device Product and Services
Table 19. Teikoku Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. Teikoku Recent Developments/Updates
Table 21. Nitto Denko Basic Information, Manufacturing Base and Competitors
Table 22. Nitto Denko Major Business
Table 23. Nitto Denko Passive Transdermal Drug Delivery Device Product and Services
Table 24. Nitto Denko Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Nitto Denko Recent Developments/Updates
Table 26. MedPharm Basic Information, Manufacturing Base and Competitors
Table 27. MedPharm Major Business
Table 28. MedPharm Passive Transdermal Drug Delivery Device Product and Services
Table 29. MedPharm Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. MedPharm Recent Developments/Updates
Table 31. NexGel Basic Information, Manufacturing Base and Competitors
Table 32. NexGel Major Business
Table 33. NexGel Passive Transdermal Drug Delivery Device Product and Services
Table 34. NexGel Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. NexGel Recent Developments/Updates
Table 36. Kindeva Drug Delivery Basic Information, Manufacturing Base and Competitors
Table 37. Kindeva Drug Delivery Major Business
Table 38. Kindeva Drug Delivery Passive Transdermal Drug Delivery Device Product and Services
Table 39. Kindeva Drug Delivery Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Kindeva Drug Delivery Recent Developments/Updates
Table 41. Noven Basic Information, Manufacturing Base and Competitors
Table 42. Noven Major Business
Table 43. Noven Passive Transdermal Drug Delivery Device Product and Services
Table 44. Noven Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Noven Recent Developments/Updates
Table 46. Teikoku Seiyaku Basic Information, Manufacturing Base and Competitors
Table 47. Teikoku Seiyaku Major Business
Table 48. Teikoku Seiyaku Passive Transdermal Drug Delivery Device Product and Services
Table 49. Teikoku Seiyaku Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Teikoku Seiyaku Recent Developments/Updates
Table 51. Ildong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 52. Ildong Pharmaceutical Major Business
Table 53. Ildong Pharmaceutical Passive Transdermal Drug Delivery Device Product and Services
Table 54. Ildong Pharmaceutical Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Ildong Pharmaceutical Recent Developments/Updates
Table 56. PassPort Technologies Basic Information, Manufacturing Base and Competitors
Table 57. PassPort Technologies Major Business
Table 58. PassPort Technologies Passive Transdermal Drug Delivery Device Product and Services
Table 59. PassPort Technologies Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. PassPort Technologies Recent Developments/Updates
Table 61. Hayao Group Basic Information, Manufacturing Base and Competitors
Table 62. Hayao Group Major Business
Table 63. Hayao Group Passive Transdermal Drug Delivery Device Product and Services
Table 64. Hayao Group Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Hayao Group Recent Developments/Updates
Table 66. Lingrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 67. Lingrui Pharmaceutical Major Business
Table 68. Lingrui Pharmaceutical Passive Transdermal Drug Delivery Device Product and Services
Table 69. Lingrui Pharmaceutical Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Lingrui Pharmaceutical Recent Developments/Updates
Table 71. CAS Microneedle Basic Information, Manufacturing Base and Competitors
Table 72. CAS Microneedle Major Business
Table 73. CAS Microneedle Passive Transdermal Drug Delivery Device Product and Services
Table 74. CAS Microneedle Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. CAS Microneedle Recent Developments/Updates
Table 76. Luye Basic Information, Manufacturing Base and Competitors
Table 77. Luye Major Business
Table 78. Luye Passive Transdermal Drug Delivery Device Product and Services
Table 79. Luye Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Luye Recent Developments/Updates
Table 81. Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 82. Tide Pharmaceutical Major Business
Table 83. Tide Pharmaceutical Passive Transdermal Drug Delivery Device Product and Services
Table 84. Tide Pharmaceutical Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Tide Pharmaceutical Recent Developments/Updates
Table 86. Jiudian Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 87. Jiudian Pharmaceutical Major Business
Table 88. Jiudian Pharmaceutical Passive Transdermal Drug Delivery Device Product and Services
Table 89. Jiudian Pharmaceutical Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Jiudian Pharmaceutical Recent Developments/Updates
Table 91. LianSN Pharm Basic Information, Manufacturing Base and Competitors
Table 92. LianSN Pharm Major Business
Table 93. LianSN Pharm Passive Transdermal Drug Delivery Device Product and Services
Table 94. LianSN Pharm Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. LianSN Pharm Recent Developments/Updates
Table 96. Global Passive Transdermal Drug Delivery Device Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 97. Global Passive Transdermal Drug Delivery Device Revenue by Manufacturer (2021-2026) & (USD Million)
Table 98. Global Passive Transdermal Drug Delivery Device Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 99. Market Position of Manufacturers in Passive Transdermal Drug Delivery Device, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 100. Head Office and Passive Transdermal Drug Delivery Device Production Site of Key Manufacturer
Table 101. Passive Transdermal Drug Delivery Device Market: Company Product Type Footprint
Table 102. Passive Transdermal Drug Delivery Device Market: Company Product Application Footprint
Table 103. Passive Transdermal Drug Delivery Device New Market Entrants and Barriers to Market Entry
Table 104. Passive Transdermal Drug Delivery Device Mergers, Acquisition, Agreements, and Collaborations
Table 105. Global Passive Transdermal Drug Delivery Device Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 106. Global Passive Transdermal Drug Delivery Device Sales Quantity by Region (2021-2026) & (Units)
Table 107. Global Passive Transdermal Drug Delivery Device Sales Quantity by Region (2027-2032) & (Units)
Table 108. Global Passive Transdermal Drug Delivery Device Consumption Value by Region (2021-2026) & (USD Million)
Table 109. Global Passive Transdermal Drug Delivery Device Consumption Value by Region (2027-2032) & (USD Million)
Table 110. Global Passive Transdermal Drug Delivery Device Average Price by Region (2021-2026) & (USD/Unit)
Table 111. Global Passive Transdermal Drug Delivery Device Average Price by Region (2027-2032) & (USD/Unit)
Table 112. Global Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2026) & (Units)
Table 113. Global Passive Transdermal Drug Delivery Device Sales Quantity by Type (2027-2032) & (Units)
Table 114. Global Passive Transdermal Drug Delivery Device Consumption Value by Type (2021-2026) & (USD Million)
Table 115. Global Passive Transdermal Drug Delivery Device Consumption Value by Type (2027-2032) & (USD Million)
Table 116. Global Passive Transdermal Drug Delivery Device Average Price by Type (2021-2026) & (USD/Unit)
Table 117. Global Passive Transdermal Drug Delivery Device Average Price by Type (2027-2032) & (USD/Unit)
Table 118. Global Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2026) & (Units)
Table 119. Global Passive Transdermal Drug Delivery Device Sales Quantity by Application (2027-2032) & (Units)
Table 120. Global Passive Transdermal Drug Delivery Device Consumption Value by Application (2021-2026) & (USD Million)
Table 121. Global Passive Transdermal Drug Delivery Device Consumption Value by Application (2027-2032) & (USD Million)
Table 122. Global Passive Transdermal Drug Delivery Device Average Price by Application (2021-2026) & (USD/Unit)
Table 123. Global Passive Transdermal Drug Delivery Device Average Price by Application (2027-2032) & (USD/Unit)
Table 124. North America Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2026) & (Units)
Table 125. North America Passive Transdermal Drug Delivery Device Sales Quantity by Type (2027-2032) & (Units)
Table 126. North America Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2026) & (Units)
Table 127. North America Passive Transdermal Drug Delivery Device Sales Quantity by Application (2027-2032) & (Units)
Table 128. North America Passive Transdermal Drug Delivery Device Sales Quantity by Country (2021-2026) & (Units)
Table 129. North America Passive Transdermal Drug Delivery Device Sales Quantity by Country (2027-2032) & (Units)
Table 130. North America Passive Transdermal Drug Delivery Device Consumption Value by Country (2021-2026) & (USD Million)
Table 131. North America Passive Transdermal Drug Delivery Device Consumption Value by Country (2027-2032) & (USD Million)
Table 132. Europe Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2026) & (Units)
Table 133. Europe Passive Transdermal Drug Delivery Device Sales Quantity by Type (2027-2032) & (Units)
Table 134. Europe Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2026) & (Units)
Table 135. Europe Passive Transdermal Drug Delivery Device Sales Quantity by Application (2027-2032) & (Units)
Table 136. Europe Passive Transdermal Drug Delivery Device Sales Quantity by Country (2021-2026) & (Units)
Table 137. Europe Passive Transdermal Drug Delivery Device Sales Quantity by Country (2027-2032) & (Units)
Table 138. Europe Passive Transdermal Drug Delivery Device Consumption Value by Country (2021-2026) & (USD Million)
Table 139. Europe Passive Transdermal Drug Delivery Device Consumption Value by Country (2027-2032) & (USD Million)
Table 140. Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2026) & (Units)
Table 141. Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity by Type (2027-2032) & (Units)
Table 142. Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2026) & (Units)
Table 143. Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity by Application (2027-2032) & (Units)
Table 144. Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity by Region (2021-2026) & (Units)
Table 145. Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity by Region (2027-2032) & (Units)
Table 146. Asia-Pacific Passive Transdermal Drug Delivery Device Consumption Value by Region (2021-2026) & (USD Million)
Table 147. Asia-Pacific Passive Transdermal Drug Delivery Device Consumption Value by Region (2027-2032) & (USD Million)
Table 148. South America Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2026) & (Units)
Table 149. South America Passive Transdermal Drug Delivery Device Sales Quantity by Type (2027-2032) & (Units)
Table 150. South America Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2026) & (Units)
Table 151. South America Passive Transdermal Drug Delivery Device Sales Quantity by Application (2027-2032) & (Units)
Table 152. South America Passive Transdermal Drug Delivery Device Sales Quantity by Country (2021-2026) & (Units)
Table 153. South America Passive Transdermal Drug Delivery Device Sales Quantity by Country (2027-2032) & (Units)
Table 154. South America Passive Transdermal Drug Delivery Device Consumption Value by Country (2021-2026) & (USD Million)
Table 155. South America Passive Transdermal Drug Delivery Device Consumption Value by Country (2027-2032) & (USD Million)
Table 156. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2026) & (Units)
Table 157. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity by Type (2027-2032) & (Units)
Table 158. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2026) & (Units)
Table 159. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity by Application (2027-2032) & (Units)
Table 160. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity by Country (2021-2026) & (Units)
Table 161. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity by Country (2027-2032) & (Units)
Table 162. Middle East & Africa Passive Transdermal Drug Delivery Device Consumption Value by Country (2021-2026) & (USD Million)
Table 163. Middle East & Africa Passive Transdermal Drug Delivery Device Consumption Value by Country (2027-2032) & (USD Million)
Table 164. Passive Transdermal Drug Delivery Device Raw Material
Table 165. Key Manufacturers of Passive Transdermal Drug Delivery Device Raw Materials
Table 166. Passive Transdermal Drug Delivery Device Typical Distributors
Table 167. Passive Transdermal Drug Delivery Device Typical Customers
Table 1. Global Passive Transdermal Drug Delivery Device Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Passive Transdermal Drug Delivery Device Consumption Value by Drug Type, (USD Million), 2021 & 2025 & 2032
Table 3. Global Passive Transdermal Drug Delivery Device Consumption Value by Interaction Mechanism, (USD Million), 2021 & 2025 & 2032
Table 4. Global Passive Transdermal Drug Delivery Device Consumption Value by Drug Release Rate, (USD Million), 2021 & 2025 & 2032
Table 5. Global Passive Transdermal Drug Delivery Device Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Hisamitsu Basic Information, Manufacturing Base and Competitors
Table 7. Hisamitsu Major Business
Table 8. Hisamitsu Passive Transdermal Drug Delivery Device Product and Services
Table 9. Hisamitsu Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Hisamitsu Recent Developments/Updates
Table 11. LTS Lohmann Therapie-Systeme Basic Information, Manufacturing Base and Competitors
Table 12. LTS Lohmann Therapie-Systeme Major Business
Table 13. LTS Lohmann Therapie-Systeme Passive Transdermal Drug Delivery Device Product and Services
Table 14. LTS Lohmann Therapie-Systeme Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. LTS Lohmann Therapie-Systeme Recent Developments/Updates
Table 16. Teikoku Basic Information, Manufacturing Base and Competitors
Table 17. Teikoku Major Business
Table 18. Teikoku Passive Transdermal Drug Delivery Device Product and Services
Table 19. Teikoku Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. Teikoku Recent Developments/Updates
Table 21. Nitto Denko Basic Information, Manufacturing Base and Competitors
Table 22. Nitto Denko Major Business
Table 23. Nitto Denko Passive Transdermal Drug Delivery Device Product and Services
Table 24. Nitto Denko Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Nitto Denko Recent Developments/Updates
Table 26. MedPharm Basic Information, Manufacturing Base and Competitors
Table 27. MedPharm Major Business
Table 28. MedPharm Passive Transdermal Drug Delivery Device Product and Services
Table 29. MedPharm Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. MedPharm Recent Developments/Updates
Table 31. NexGel Basic Information, Manufacturing Base and Competitors
Table 32. NexGel Major Business
Table 33. NexGel Passive Transdermal Drug Delivery Device Product and Services
Table 34. NexGel Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. NexGel Recent Developments/Updates
Table 36. Kindeva Drug Delivery Basic Information, Manufacturing Base and Competitors
Table 37. Kindeva Drug Delivery Major Business
Table 38. Kindeva Drug Delivery Passive Transdermal Drug Delivery Device Product and Services
Table 39. Kindeva Drug Delivery Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Kindeva Drug Delivery Recent Developments/Updates
Table 41. Noven Basic Information, Manufacturing Base and Competitors
Table 42. Noven Major Business
Table 43. Noven Passive Transdermal Drug Delivery Device Product and Services
Table 44. Noven Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Noven Recent Developments/Updates
Table 46. Teikoku Seiyaku Basic Information, Manufacturing Base and Competitors
Table 47. Teikoku Seiyaku Major Business
Table 48. Teikoku Seiyaku Passive Transdermal Drug Delivery Device Product and Services
Table 49. Teikoku Seiyaku Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Teikoku Seiyaku Recent Developments/Updates
Table 51. Ildong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 52. Ildong Pharmaceutical Major Business
Table 53. Ildong Pharmaceutical Passive Transdermal Drug Delivery Device Product and Services
Table 54. Ildong Pharmaceutical Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Ildong Pharmaceutical Recent Developments/Updates
Table 56. PassPort Technologies Basic Information, Manufacturing Base and Competitors
Table 57. PassPort Technologies Major Business
Table 58. PassPort Technologies Passive Transdermal Drug Delivery Device Product and Services
Table 59. PassPort Technologies Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. PassPort Technologies Recent Developments/Updates
Table 61. Hayao Group Basic Information, Manufacturing Base and Competitors
Table 62. Hayao Group Major Business
Table 63. Hayao Group Passive Transdermal Drug Delivery Device Product and Services
Table 64. Hayao Group Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Hayao Group Recent Developments/Updates
Table 66. Lingrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 67. Lingrui Pharmaceutical Major Business
Table 68. Lingrui Pharmaceutical Passive Transdermal Drug Delivery Device Product and Services
Table 69. Lingrui Pharmaceutical Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Lingrui Pharmaceutical Recent Developments/Updates
Table 71. CAS Microneedle Basic Information, Manufacturing Base and Competitors
Table 72. CAS Microneedle Major Business
Table 73. CAS Microneedle Passive Transdermal Drug Delivery Device Product and Services
Table 74. CAS Microneedle Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. CAS Microneedle Recent Developments/Updates
Table 76. Luye Basic Information, Manufacturing Base and Competitors
Table 77. Luye Major Business
Table 78. Luye Passive Transdermal Drug Delivery Device Product and Services
Table 79. Luye Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Luye Recent Developments/Updates
Table 81. Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 82. Tide Pharmaceutical Major Business
Table 83. Tide Pharmaceutical Passive Transdermal Drug Delivery Device Product and Services
Table 84. Tide Pharmaceutical Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Tide Pharmaceutical Recent Developments/Updates
Table 86. Jiudian Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 87. Jiudian Pharmaceutical Major Business
Table 88. Jiudian Pharmaceutical Passive Transdermal Drug Delivery Device Product and Services
Table 89. Jiudian Pharmaceutical Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Jiudian Pharmaceutical Recent Developments/Updates
Table 91. LianSN Pharm Basic Information, Manufacturing Base and Competitors
Table 92. LianSN Pharm Major Business
Table 93. LianSN Pharm Passive Transdermal Drug Delivery Device Product and Services
Table 94. LianSN Pharm Passive Transdermal Drug Delivery Device Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. LianSN Pharm Recent Developments/Updates
Table 96. Global Passive Transdermal Drug Delivery Device Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 97. Global Passive Transdermal Drug Delivery Device Revenue by Manufacturer (2021-2026) & (USD Million)
Table 98. Global Passive Transdermal Drug Delivery Device Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 99. Market Position of Manufacturers in Passive Transdermal Drug Delivery Device, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 100. Head Office and Passive Transdermal Drug Delivery Device Production Site of Key Manufacturer
Table 101. Passive Transdermal Drug Delivery Device Market: Company Product Type Footprint
Table 102. Passive Transdermal Drug Delivery Device Market: Company Product Application Footprint
Table 103. Passive Transdermal Drug Delivery Device New Market Entrants and Barriers to Market Entry
Table 104. Passive Transdermal Drug Delivery Device Mergers, Acquisition, Agreements, and Collaborations
Table 105. Global Passive Transdermal Drug Delivery Device Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 106. Global Passive Transdermal Drug Delivery Device Sales Quantity by Region (2021-2026) & (Units)
Table 107. Global Passive Transdermal Drug Delivery Device Sales Quantity by Region (2027-2032) & (Units)
Table 108. Global Passive Transdermal Drug Delivery Device Consumption Value by Region (2021-2026) & (USD Million)
Table 109. Global Passive Transdermal Drug Delivery Device Consumption Value by Region (2027-2032) & (USD Million)
Table 110. Global Passive Transdermal Drug Delivery Device Average Price by Region (2021-2026) & (USD/Unit)
Table 111. Global Passive Transdermal Drug Delivery Device Average Price by Region (2027-2032) & (USD/Unit)
Table 112. Global Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2026) & (Units)
Table 113. Global Passive Transdermal Drug Delivery Device Sales Quantity by Type (2027-2032) & (Units)
Table 114. Global Passive Transdermal Drug Delivery Device Consumption Value by Type (2021-2026) & (USD Million)
Table 115. Global Passive Transdermal Drug Delivery Device Consumption Value by Type (2027-2032) & (USD Million)
Table 116. Global Passive Transdermal Drug Delivery Device Average Price by Type (2021-2026) & (USD/Unit)
Table 117. Global Passive Transdermal Drug Delivery Device Average Price by Type (2027-2032) & (USD/Unit)
Table 118. Global Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2026) & (Units)
Table 119. Global Passive Transdermal Drug Delivery Device Sales Quantity by Application (2027-2032) & (Units)
Table 120. Global Passive Transdermal Drug Delivery Device Consumption Value by Application (2021-2026) & (USD Million)
Table 121. Global Passive Transdermal Drug Delivery Device Consumption Value by Application (2027-2032) & (USD Million)
Table 122. Global Passive Transdermal Drug Delivery Device Average Price by Application (2021-2026) & (USD/Unit)
Table 123. Global Passive Transdermal Drug Delivery Device Average Price by Application (2027-2032) & (USD/Unit)
Table 124. North America Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2026) & (Units)
Table 125. North America Passive Transdermal Drug Delivery Device Sales Quantity by Type (2027-2032) & (Units)
Table 126. North America Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2026) & (Units)
Table 127. North America Passive Transdermal Drug Delivery Device Sales Quantity by Application (2027-2032) & (Units)
Table 128. North America Passive Transdermal Drug Delivery Device Sales Quantity by Country (2021-2026) & (Units)
Table 129. North America Passive Transdermal Drug Delivery Device Sales Quantity by Country (2027-2032) & (Units)
Table 130. North America Passive Transdermal Drug Delivery Device Consumption Value by Country (2021-2026) & (USD Million)
Table 131. North America Passive Transdermal Drug Delivery Device Consumption Value by Country (2027-2032) & (USD Million)
Table 132. Europe Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2026) & (Units)
Table 133. Europe Passive Transdermal Drug Delivery Device Sales Quantity by Type (2027-2032) & (Units)
Table 134. Europe Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2026) & (Units)
Table 135. Europe Passive Transdermal Drug Delivery Device Sales Quantity by Application (2027-2032) & (Units)
Table 136. Europe Passive Transdermal Drug Delivery Device Sales Quantity by Country (2021-2026) & (Units)
Table 137. Europe Passive Transdermal Drug Delivery Device Sales Quantity by Country (2027-2032) & (Units)
Table 138. Europe Passive Transdermal Drug Delivery Device Consumption Value by Country (2021-2026) & (USD Million)
Table 139. Europe Passive Transdermal Drug Delivery Device Consumption Value by Country (2027-2032) & (USD Million)
Table 140. Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2026) & (Units)
Table 141. Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity by Type (2027-2032) & (Units)
Table 142. Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2026) & (Units)
Table 143. Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity by Application (2027-2032) & (Units)
Table 144. Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity by Region (2021-2026) & (Units)
Table 145. Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity by Region (2027-2032) & (Units)
Table 146. Asia-Pacific Passive Transdermal Drug Delivery Device Consumption Value by Region (2021-2026) & (USD Million)
Table 147. Asia-Pacific Passive Transdermal Drug Delivery Device Consumption Value by Region (2027-2032) & (USD Million)
Table 148. South America Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2026) & (Units)
Table 149. South America Passive Transdermal Drug Delivery Device Sales Quantity by Type (2027-2032) & (Units)
Table 150. South America Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2026) & (Units)
Table 151. South America Passive Transdermal Drug Delivery Device Sales Quantity by Application (2027-2032) & (Units)
Table 152. South America Passive Transdermal Drug Delivery Device Sales Quantity by Country (2021-2026) & (Units)
Table 153. South America Passive Transdermal Drug Delivery Device Sales Quantity by Country (2027-2032) & (Units)
Table 154. South America Passive Transdermal Drug Delivery Device Consumption Value by Country (2021-2026) & (USD Million)
Table 155. South America Passive Transdermal Drug Delivery Device Consumption Value by Country (2027-2032) & (USD Million)
Table 156. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity by Type (2021-2026) & (Units)
Table 157. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity by Type (2027-2032) & (Units)
Table 158. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity by Application (2021-2026) & (Units)
Table 159. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity by Application (2027-2032) & (Units)
Table 160. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity by Country (2021-2026) & (Units)
Table 161. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity by Country (2027-2032) & (Units)
Table 162. Middle East & Africa Passive Transdermal Drug Delivery Device Consumption Value by Country (2021-2026) & (USD Million)
Table 163. Middle East & Africa Passive Transdermal Drug Delivery Device Consumption Value by Country (2027-2032) & (USD Million)
Table 164. Passive Transdermal Drug Delivery Device Raw Material
Table 165. Key Manufacturers of Passive Transdermal Drug Delivery Device Raw Materials
Table 166. Passive Transdermal Drug Delivery Device Typical Distributors
Table 167. Passive Transdermal Drug Delivery Device Typical Customers
LIST OF FIGURES
Figure 1. Passive Transdermal Drug Delivery Device Picture
Figure 2. Global Passive Transdermal Drug Delivery Device Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Type in 2025
Figure 4. Patch Drug Delivery Examples
Figure 5. Cream Drug Delivery Examples
Figure 6. Plaster Drug Delivery Examples
Figure 7. Microneedle Drug Delivery Examples
Figure 8. Liposome Drug Delivery Examples
Figure 9. Global Passive Transdermal Drug Delivery Device Revenue by Drug Type, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Drug Type in 2025
Figure 11. Small Molecule Drugs Examples
Figure 12. Protein Drugs Examples
Figure 13. Nucleic Acid Drugs Examples
Figure 14. Global Passive Transdermal Drug Delivery Device Revenue by Interaction Mechanism, (USD Million), 2021 & 2025 & 2032
Figure 15. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Interaction Mechanism in 2025
Figure 16. Diffusion Only Drug Delivery Examples
Figure 17. Penetration Enhancer Assisted Drug Delivery Examples
Figure 18. Carrier Mediated Drug Delivery Examples
Figure 19. Global Passive Transdermal Drug Delivery Device Revenue by Drug Release Rate, (USD Million), 2021 & 2025 & 2032
Figure 20. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Drug Release Rate in 2025
Figure 21. Immediate Release Drug Delivery Examples
Figure 22. Sustained Release Drug Delivery Examples
Figure 23. Controlled Release Drug Delivery Examples
Figure 24. Global Passive Transdermal Drug Delivery Device Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 25. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Application in 2025
Figure 26. Neurological Disorders Treatment Examples
Figure 27. Cardiovascular Diseases Treatment Examples
Figure 28. Hormone Replacement Therapy Examples
Figure 29. Global Passive Transdermal Drug Delivery Device Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 30. Global Passive Transdermal Drug Delivery Device Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 31. Global Passive Transdermal Drug Delivery Device Sales Quantity (2021-2032) & (Units)
Figure 32. Global Passive Transdermal Drug Delivery Device Price (2021-2032) & (USD/Unit)
Figure 33. Global Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Manufacturer in 2025
Figure 34. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Manufacturer in 2025
Figure 35. Producer Shipments of Passive Transdermal Drug Delivery Device by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 36. Top 3 Passive Transdermal Drug Delivery Device Manufacturer (Revenue) Market Share in 2025
Figure 37. Top 6 Passive Transdermal Drug Delivery Device Manufacturer (Revenue) Market Share in 2025
Figure 38. Global Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Region (2021-2032)
Figure 39. Global Passive Transdermal Drug Delivery Device Consumption Value Market Share by Region (2021-2032)
Figure 40. North America Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 41. Europe Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 42. Asia-Pacific Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 43. South America Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 44. Middle East & Africa Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 45. Global Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Type (2021-2032)
Figure 46. Global Passive Transdermal Drug Delivery Device Consumption Value Market Share by Type (2021-2032)
Figure 47. Global Passive Transdermal Drug Delivery Device Average Price by Type (2021-2032) & (USD/Unit)
Figure 48. Global Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Application (2021-2032)
Figure 49. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Application (2021-2032)
Figure 50. Global Passive Transdermal Drug Delivery Device Average Price by Application (2021-2032) & (USD/Unit)
Figure 51. North America Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Type (2021-2032)
Figure 52. North America Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Application (2021-2032)
Figure 53. North America Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Country (2021-2032)
Figure 54. North America Passive Transdermal Drug Delivery Device Consumption Value Market Share by Country (2021-2032)
Figure 55. United States Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 56. Canada Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 57. Mexico Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 58. Europe Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Type (2021-2032)
Figure 59. Europe Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Application (2021-2032)
Figure 60. Europe Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Country (2021-2032)
Figure 61. Europe Passive Transdermal Drug Delivery Device Consumption Value Market Share by Country (2021-2032)
Figure 62. Germany Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 63. France Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 64. United Kingdom Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 65. Russia Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 66. Italy Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 67. Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Type (2021-2032)
Figure 68. Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Application (2021-2032)
Figure 69. Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Region (2021-2032)
Figure 70. Asia-Pacific Passive Transdermal Drug Delivery Device Consumption Value Market Share by Region (2021-2032)
Figure 71. China Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 72. Japan Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 73. South Korea Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 74. India Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 75. Southeast Asia Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 76. Australia Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 77. South America Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Type (2021-2032)
Figure 78. South America Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Application (2021-2032)
Figure 79. South America Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Country (2021-2032)
Figure 80. South America Passive Transdermal Drug Delivery Device Consumption Value Market Share by Country (2021-2032)
Figure 81. Brazil Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 82. Argentina Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 83. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Type (2021-2032)
Figure 84. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Application (2021-2032)
Figure 85. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Country (2021-2032)
Figure 86. Middle East & Africa Passive Transdermal Drug Delivery Device Consumption Value Market Share by Country (2021-2032)
Figure 87. Turkey Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 88. Egypt Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 89. Saudi Arabia Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 90. South Africa Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 91. Passive Transdermal Drug Delivery Device Market Drivers
Figure 92. Passive Transdermal Drug Delivery Device Market Restraints
Figure 93. Passive Transdermal Drug Delivery Device Market Trends
Figure 94. Porters Five Forces Analysis
Figure 95. Manufacturing Cost Structure Analysis of Passive Transdermal Drug Delivery Device in 2025
Figure 96. Manufacturing Process Analysis of Passive Transdermal Drug Delivery Device
Figure 97. Passive Transdermal Drug Delivery Device Industrial Chain
Figure 98. Sales Channel: Direct to End-User vs Distributors
Figure 99. Direct Channel Pros & Cons
Figure 100. Indirect Channel Pros & Cons
Figure 101. Methodology
Figure 102. Research Process and Data Source
Figure 1. Passive Transdermal Drug Delivery Device Picture
Figure 2. Global Passive Transdermal Drug Delivery Device Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Type in 2025
Figure 4. Patch Drug Delivery Examples
Figure 5. Cream Drug Delivery Examples
Figure 6. Plaster Drug Delivery Examples
Figure 7. Microneedle Drug Delivery Examples
Figure 8. Liposome Drug Delivery Examples
Figure 9. Global Passive Transdermal Drug Delivery Device Revenue by Drug Type, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Drug Type in 2025
Figure 11. Small Molecule Drugs Examples
Figure 12. Protein Drugs Examples
Figure 13. Nucleic Acid Drugs Examples
Figure 14. Global Passive Transdermal Drug Delivery Device Revenue by Interaction Mechanism, (USD Million), 2021 & 2025 & 2032
Figure 15. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Interaction Mechanism in 2025
Figure 16. Diffusion Only Drug Delivery Examples
Figure 17. Penetration Enhancer Assisted Drug Delivery Examples
Figure 18. Carrier Mediated Drug Delivery Examples
Figure 19. Global Passive Transdermal Drug Delivery Device Revenue by Drug Release Rate, (USD Million), 2021 & 2025 & 2032
Figure 20. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Drug Release Rate in 2025
Figure 21. Immediate Release Drug Delivery Examples
Figure 22. Sustained Release Drug Delivery Examples
Figure 23. Controlled Release Drug Delivery Examples
Figure 24. Global Passive Transdermal Drug Delivery Device Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 25. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Application in 2025
Figure 26. Neurological Disorders Treatment Examples
Figure 27. Cardiovascular Diseases Treatment Examples
Figure 28. Hormone Replacement Therapy Examples
Figure 29. Global Passive Transdermal Drug Delivery Device Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 30. Global Passive Transdermal Drug Delivery Device Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 31. Global Passive Transdermal Drug Delivery Device Sales Quantity (2021-2032) & (Units)
Figure 32. Global Passive Transdermal Drug Delivery Device Price (2021-2032) & (USD/Unit)
Figure 33. Global Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Manufacturer in 2025
Figure 34. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Manufacturer in 2025
Figure 35. Producer Shipments of Passive Transdermal Drug Delivery Device by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 36. Top 3 Passive Transdermal Drug Delivery Device Manufacturer (Revenue) Market Share in 2025
Figure 37. Top 6 Passive Transdermal Drug Delivery Device Manufacturer (Revenue) Market Share in 2025
Figure 38. Global Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Region (2021-2032)
Figure 39. Global Passive Transdermal Drug Delivery Device Consumption Value Market Share by Region (2021-2032)
Figure 40. North America Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 41. Europe Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 42. Asia-Pacific Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 43. South America Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 44. Middle East & Africa Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 45. Global Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Type (2021-2032)
Figure 46. Global Passive Transdermal Drug Delivery Device Consumption Value Market Share by Type (2021-2032)
Figure 47. Global Passive Transdermal Drug Delivery Device Average Price by Type (2021-2032) & (USD/Unit)
Figure 48. Global Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Application (2021-2032)
Figure 49. Global Passive Transdermal Drug Delivery Device Revenue Market Share by Application (2021-2032)
Figure 50. Global Passive Transdermal Drug Delivery Device Average Price by Application (2021-2032) & (USD/Unit)
Figure 51. North America Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Type (2021-2032)
Figure 52. North America Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Application (2021-2032)
Figure 53. North America Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Country (2021-2032)
Figure 54. North America Passive Transdermal Drug Delivery Device Consumption Value Market Share by Country (2021-2032)
Figure 55. United States Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 56. Canada Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 57. Mexico Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 58. Europe Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Type (2021-2032)
Figure 59. Europe Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Application (2021-2032)
Figure 60. Europe Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Country (2021-2032)
Figure 61. Europe Passive Transdermal Drug Delivery Device Consumption Value Market Share by Country (2021-2032)
Figure 62. Germany Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 63. France Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 64. United Kingdom Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 65. Russia Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 66. Italy Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 67. Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Type (2021-2032)
Figure 68. Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Application (2021-2032)
Figure 69. Asia-Pacific Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Region (2021-2032)
Figure 70. Asia-Pacific Passive Transdermal Drug Delivery Device Consumption Value Market Share by Region (2021-2032)
Figure 71. China Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 72. Japan Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 73. South Korea Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 74. India Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 75. Southeast Asia Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 76. Australia Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 77. South America Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Type (2021-2032)
Figure 78. South America Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Application (2021-2032)
Figure 79. South America Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Country (2021-2032)
Figure 80. South America Passive Transdermal Drug Delivery Device Consumption Value Market Share by Country (2021-2032)
Figure 81. Brazil Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 82. Argentina Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 83. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Type (2021-2032)
Figure 84. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Application (2021-2032)
Figure 85. Middle East & Africa Passive Transdermal Drug Delivery Device Sales Quantity Market Share by Country (2021-2032)
Figure 86. Middle East & Africa Passive Transdermal Drug Delivery Device Consumption Value Market Share by Country (2021-2032)
Figure 87. Turkey Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 88. Egypt Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 89. Saudi Arabia Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 90. South Africa Passive Transdermal Drug Delivery Device Consumption Value (2021-2032) & (USD Million)
Figure 91. Passive Transdermal Drug Delivery Device Market Drivers
Figure 92. Passive Transdermal Drug Delivery Device Market Restraints
Figure 93. Passive Transdermal Drug Delivery Device Market Trends
Figure 94. Porters Five Forces Analysis
Figure 95. Manufacturing Cost Structure Analysis of Passive Transdermal Drug Delivery Device in 2025
Figure 96. Manufacturing Process Analysis of Passive Transdermal Drug Delivery Device
Figure 97. Passive Transdermal Drug Delivery Device Industrial Chain
Figure 98. Sales Channel: Direct to End-User vs Distributors
Figure 99. Direct Channel Pros & Cons
Figure 100. Indirect Channel Pros & Cons
Figure 101. Methodology
Figure 102. Research Process and Data Source
